A realistic starting point is typically a prior art disclosure as a whole. Absent a specific reason or pointer in the disclosure itself (or based on common general knowledge) to do so, the selection…
The lesson of this year's BIO International Convention in San Diego is not that the market has finally discovered the Unified Patent Court; it has been aware of it for some time. It is that life…
As discussed in my previous post on this Blog, the UPC’s current approach of granting pan-UPC relief across all the Contracting Member States (CMS), based merely on a formal reliance on Article 34…
The most uncomfortable thing one can say about the Unified Patent Court is not that it is becoming too German. It is that it may never have been built, and is still not quite treated, as a European…
A court of appeal is not a scoreboard, and it is worth saying so plainly at this stage of the debate on the Unified Patent Court. The discussion about how cases are distributed across the UPC’s…
This week, I have the pleasure of speaking in Amsterdam at C5’s 19th Annual Forum on Pharma & Biotech Patent Litigation in Europe, in a panel devoted to running and defending preliminary injunctions…
"Gedanken ohne Inhalt sind leer, Anschauungen ohne Begriffe sind blind." — Immanuel Kant (Thoughts without content are empty, intuitions without concepts are blind.) Recent reactions to my earlier…
Applications in the UPC for Requests to Produce Evidence under r.190 RoP are rare beasts. An Order following one such application was made on 14 April 2026 by the Brussels LD (full panel) in the case…
A ball may reach the line and still not cross it. Jurisdiction obeys the same logic.The order delivered on 13 March 2026 by the Court of Appeal of the Unified Patent Court in Adobe Inc, OpenAI LP &…
